Format

Send to

Choose Destination
Dev Med Child Neurol. 2015 Dec;57(12):1183-6. doi: 10.1111/dmcn.12927. Epub 2015 Sep 23.

Relapsing encephalopathy with cerebellar ataxia related to an ATP1A3 mutation.

Author information

1
Department of Genetics, AP-HP, La Pitié-Salpêtrière University Hospital, Paris, France.
2
Inserm, Institut du Cerveau et de la Moelle épinière, Sorbonne Universités, UPMC University Paris, Paris, France.
3
Department of Medical Genetics, Lyon University Hospital, Lyon, France.
4
Department of Neurology, AP-HP, La Pitié-Salpêtrière University Hospital, Paris, France.
5
Bioclinic and Genetic Unit of Neurometabolic Diseases, Pitié-Salpêtrière Hospital, Paris, France.

Abstract

ATP1A3, the gene encoding the α3-subunit of the Na(+) /K(+) -ATPase pump, has been involved in four clinical neurological entities: (1) alternating hemiplegia of childhood (AHC); (2) rapid-onset dystonia parkinsonism (RDP); (3) CAPOS (cerebellar ataxia, areflexia, pes cavus, optic atrophy, sensorineural hearing loss) syndrome; and (4) early infantile epileptic encephalopathy. Here, we report on a 34-year-old female presenting with a new ATP1A3-related entity involving a relapsing encephalopathy characterized by recurrent episodes of cerebellar ataxia and altered consciousness during febrile illnesses. The term RECA is suggested - relapsing encephalopathy with cerebellar ataxia. The phenotype of this patient, resembling mitochondrial oxidative phosphorylation defects, emphasizes the possible role of brain energy deficiency in patients with ATP1A3 mutations. Rather than multiple overlapping syndromes, ATP1A3-related disorders might be seen as a phenotypic continuum.

PMID:
26400718
DOI:
10.1111/dmcn.12927
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center